How much of a cancer drug is too much? Patients, researchers challenge FDA dosages
huck Manski, an economist at Northwestern University, sits at home in Chicago.
After suffering severe side effects from a drug he took to treat melanoma, he studied the cancer literature and decided he could stop the treatment early.